Helix BioPharma Appoints Deloitte as Strategic Advisor to Explore Partnering and Licensing Opportunities
pharmaceutical investing Helix BioPharma Corp. Announces Licence for Worldwide Right to Anti-CEACAM6 Antibody From the Government of Canada
Helix BioPharma Announces the Signing of a Non-Binding Letter of Intent With ProMab Biotechnologies to Develop Cell Based Therapies
Helix BioPharma Corp. Announces L-DOS47 Immuno-Oncology Scientific Presentation at the Medical University of Warsaw
Allied Critical Metals Closes First Tranche of Oversubscribed Non-Brokered Private Placement and Upsize to $5m of the Offering
Harvest Gold Kicks Off Drilling at Mosseau, Launches Urban-Barry Till Program, and Completes Labelle Mag Survey
